Five lupus patients in England entered remission after undergoing a groundbreaking NHS trial that genetically modified their T-cells, offering hope for a potential cure.

The therapy works by genetically modifying cells to enable the body’s own immune system to recognise and attack problem cells

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…